Signet, Bionpharma and GMS Form Pharma Nobis to Acquire Fagron's U.S. Contract Manufacturing Business
February 4, 2022
An investor consortium led by Signet Healthcare Partners with Bionpharma, Inc. and GMS Capital Partners formed Pharma Nobis, LLC to acquire Fagron's U.S. contract manufacturing business and manufacturing facility in Texarkana, Texas. Fagron will retain a 20% interest in the new company; Todd Daviau was named CEO and the investors said they will seek to grow the contract manufacturing and private-label capabilities for consumer healthcare and retail customers.
- Buyers
- Signet Healthcare Partners, Bionpharma, Inc., GMS Capital Partners LLC, Pharma Nobis, LLC
- Targets
- Fagron's U.S. contract manufacturing business and manufacturing facility (Texarkana, Texas)
- Sellers
- Fagron
- Industry
- Pharmaceuticals
- Location
- Texas, United States
- Transaction Type
- Divestiture
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.